160 related articles for article (PubMed ID: 9514892)
1. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.
Dahlen JR; Foster DC; Kisiel W
Biochem Biophys Res Commun; 1998 Mar; 244(1):172-7. PubMed ID: 9514892
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification, and inhibitory properties of human proteinase inhibitor.
Dahlen JR; Foster DC; Kisiel W
Biochemistry; 1997 Dec; 36(48):14874-82. PubMed ID: 9402754
[TBL] [Abstract][Full Text] [Related]
3. Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin A.
Dahlen JR; Foster DC; Kisiel W
Biochem Biophys Res Commun; 1997 Sep; 238(2):329-33. PubMed ID: 9299506
[TBL] [Abstract][Full Text] [Related]
4. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
5. Expression, Purification, and Inhibitory Properties of Human Proteinase Inhibitor 8.
Dahlen JR; Foster DC; Kisiel W
Biochemistry; 1997 Dec; 36(48):14874-82. PubMed ID: 9398210
[TBL] [Abstract][Full Text] [Related]
6. Role of the P2 residue in determining the specificity of serpins.
Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory plant serpins with a sequence of three glutamine residues in the reactive center.
Hejgaard J
Biol Chem; 2005 Dec; 386(12):1319-23. PubMed ID: 16336127
[TBL] [Abstract][Full Text] [Related]
8. Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers.
Aulak KS; Davis AE; Donaldson VH; Harrison RA
Protein Sci; 1993 May; 2(5):727-32. PubMed ID: 8495195
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors.
Sprecher CA; Morgenstern KA; Mathewes S; Dahlen JR; Schrader SK; Foster DC; Kisiel W
J Biol Chem; 1995 Dec; 270(50):29854-61. PubMed ID: 8530382
[TBL] [Abstract][Full Text] [Related]
10. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
Stone SR; Le Bonniec BF
J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
13. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
14. Electrophoretic analysis of the "cross-class" interaction between novel inhibitory serpin, squamous cell carcinoma antigen-1 and cysteine proteinases.
Nawata S; Nakamura K; Tanaka T; Numa F; Suminami Y; Tsunaga N; Kakegawa H; Katunuma N; Kato H
Electrophoresis; 1997 May; 18(5):784-9. PubMed ID: 9194607
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
Kvassman JO; Verhamme I; Shore JD
Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
[TBL] [Abstract][Full Text] [Related]
16. Human cytoplasmic antiproteinase neutralizes rapidly and efficiently chymotrypsin and trypsin-like proteases utilizing distinct reactive site residues.
Riewald M; Schleef RR
J Biol Chem; 1996 Jun; 271(24):14526-32. PubMed ID: 8662739
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family.
Abts HF; Welss T; Mirmohammadsadegh A; Köhrer K; Michel G; Ruzicka T
J Mol Biol; 1999 Oct; 293(1):29-39. PubMed ID: 10512713
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory property characterization and reactive site exploration of the arrowhead proteinase inhibitor.
Yang HL; Wang LX; Zhu DX; Qi ZW
Sci China B; 1991 Jul; 34(7):832-9. PubMed ID: 1878144
[TBL] [Abstract][Full Text] [Related]
19. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
[TBL] [Abstract][Full Text] [Related]
20. Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations.
Huntington JA; Fan B; Karlsson KE; Deinum J; Lawrence DA; Gettins PG
Biochemistry; 1997 May; 36(18):5432-40. PubMed ID: 9154925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
